New Insights Into Myocardial Regeneration: How Newborn Hearts Heal—and What This Means for Adults
Heart disease is the leading cause of death worldwide, killing 7.4 million people annually. When someone has a heart attack (myocardial infarction, MI), the heart loses millions of cardiomyocytes—the muscle cells that pump blood. Unlike skin or liver cells, adult cardiomyocytes rarely divide, so the lost tissue is replaced by scarring. Over time, this scarring weakens the heart, leading to heart failure. But here’s a game-changing discovery: newborn mice can fully regenerate their hearts after injury—and scientists are now figuring out how to unlock this ability in adults.
A 2020 review in the Chinese Medical Journal by researchers from the First Affiliated Hospital of Nanjing Medical University (Chong Du, Yi Fan, Ya-Fei Li, Tian-Wen Wei, and Lian-Sheng Wang) breaks down the latest science behind myocardial regeneration. Their work focuses on the natural mechanisms that let neonatal (newborn) hearts heal—and how to reactivate these pathways in adults.
Why Neonatal Hearts Regenerate (and Adults’ Don’t)
Newborn mice (up to 7 days old) can repair 20% of their heart tissue after MI, with no scarring and full recovery of function. By day 8, this ability vanishes. The same pattern holds for humans: babies may have a brief window of regenerative potential, but it’s lost by early childhood.
The difference boils down to cardiomyocyte proliferation. Adult cardiomyocytes are “post-mitotic”—they’ve exited the cell cycle and stopped dividing. Neonatal cardiomyocytes, however, are still actively multiplying. The review identifies several key molecular players that control this switch—and how to flip it back.
1. Cell Cycle Regulators: The “On/Off Switch” for Heart Cells
Cells divide through a tightly controlled process called the cell cycle (stages like G1, S, G2, and M). For cardiomyocytes to regenerate, this cycle must reactivate—a process normally locked in adults.
The review highlights proteins that drive this cycle:
- Cyclins and CDKs: Cyclin A2 (which pushes cells from G1 to S phase) and CDK1/CDK4 (enzymes that pair with cyclins) can trigger adult cardiomyocyte division. In mice, overexpressing these proteins improved heart function after MI.
- CDK Inhibitors: Proteins like p21 and p27 block the cell cycle. Knocking out these “brakes” in mice boosted cardiomyocyte proliferation after injury.
A 2018 Cell study cited in the review found that combining four regulators—CDK1, CDK4, cyclin B1, and cyclin D1—effectively induced division in adult mouse, rat, and human cardiomyocytes. This suggests cell cycle reactivation is a core driver of regeneration.
2. Transcription Factors: Master Controllers of Regeneration
Transcription factors (TFs) are proteins that turn genes “on” or “off.” The review identifies several TFs critical to neonatal heart repair:
- Meis1: A TF that blocks cell division in adult cardiomyocytes. When scientists deleted Meis1 in newborn mice, their hearts kept regenerating longer.
- E2F2: A TF that boosts cyclin production. Overexpressing E2F2 in adult mice triggered cardiomyocyte division—a first for mature hearts.
- Tbx20: A TF that suppresses Meis1 and p21 (another cell cycle brake). In adult mice, Tbx20 overexpression improved heart function after MI by promoting cell growth.
These TFs act like “master switches,” coordinating the genes needed for regeneration.
3. Non-Coding RNAs: The Hidden Players
For years, scientists focused on protein-coding genes—but non-coding RNAs (ncRNAs) are now recognized as key regulators of heart repair. The review breaks down three types:
- miRNAs: Small molecules that silence genes. The miR-15 family (especially miR-195) is highly active in adult hearts and stops cell division. Inhibiting miR-15 in mice increased cardiomyocyte proliferation and reduced scarring after MI. MiR-128 and miR-34a have similar “anti-regeneration” roles—blocking them helps adult hearts heal.
- lncRNAs: Longer ncRNAs that regulate gene activity. The review highlights ECRAR (a fetal lncRNA) and CPR (a lncRNA that blocks cell division). Deleting CPR in mice boosted regeneration, while ECRAR activated growth pathways in adult heart cells.
- circRNAs: Circular ncRNAs that stabilize other molecules. Silencing a circRNA called Nfix in adult mice promoted cardiomyocyte division by protecting a key growth protein (Ybx1).
These ncRNAs are “hidden” because they don’t make proteins—but they’re powerful regulators of regeneration.
4. Signaling Pathways: The Communication Networks
Cells talk to each other through signaling pathways—chains of molecules that transmit messages like “divide” or “survive.” The review focuses on the Hippo pathway, a critical regulator of heart size and regeneration:
- YAP/TAZ: The “end effectors” of the Hippo pathway. When active, YAP/TAZ enter the nucleus and turn on growth genes. In newborn mice, YAP is active—but in adults, the Hippo pathway phosphorylates YAP, keeping it out of the nucleus. Inhibiting Hippo (e.g., deleting SAV1 or LATS1/2) reactivates YAP and promotes regeneration.
Other pathways like PI3K/AKT (which boosts cyclin D1) and JAK/STAT (linked to inflammation) also play roles in neonatal repair.
5. Inflammation and Hypoxia: Unexpected Helpers
Inflammation gets a bad rap—but in newborn hearts, it’s essential for regeneration. The review found that:
- Acute inflammation: Injecting a pro-inflammatory molecule (zymosan A) into newborn mice triggered cardiomyocyte division. Without interleukin-6 (IL-6) or its downstream target STAT3, regeneration failed.
- Macrophages: Newborn hearts use embryo-derived macrophages (not bone marrow-derived ones) to repair damage. These macrophages boost blood vessel growth—a key step in healing.
Hypoxia (low oxygen) is another surprise. Newborns have lower oxygen levels than adults, and the review found that:
- Mitochondrial ROS: High oxygen after birth increases reactive oxygen species (ROS), which damage DNA and stop cell division. Reducing ROS (e.g., with N-acetyl-L-cysteine) or exposing mice to 7% oxygen (simulating fetal conditions) reactivated cardiomyocyte proliferation.
- HIF-1α: A protein activated by low oxygen. HIF-1α suppresses stress pathways, letting fetal cardiomyocytes divide. Inhibiting HIF-1α in newborns blocked regeneration.
6. Protein Kinases: Fueling Cell Growth
Protein kinases are enzymes that add phosphate groups to proteins, turning them “on” or “off.” The review identifies several kinases that drive regeneration:
- ERBB2: A kinase that triggers cardiomyocyte dedifferentiation (reverting to a more “immature” state) and division. In mice, activating ERBB2 promoted repair after MI.
- p38 MAPK: A kinase that blocks cell division. Inhibiting p38 in mice increased cyclin A2/B levels and boosted regeneration—a finding supported by human clinical trials (e.g., the p38 inhibitor losmapimod).
- Pim1: A kinase that reduces cell death and promotes division. In newborn mice, Pim1 reduced infarct size and improved function.
These kinases are like “fuel injectors” for regenerating heart cells.
7. Epigenetics: The “Memory” of Regeneration
Epigenetics refers to changes in gene activity without altering DNA sequence—think of it as the “memory” of a cell’s identity. The review notes that:
- Histone modifications: Acetylation, methylation, and phosphorylation of histones (proteins that package DNA) control which genes are accessible. In adult hearts, these modifications lock cyclin genes “off.”
- DNA methylation: Adding methyl groups to DNA silences growth genes. In newborns, these genes are “unlocked”—but in adults, they’re methylated and inactive.
Epigenetic therapies (e.g., drugs that reverse methylation) could reawaken the “regeneration memory” in adult cardiomyocytes.
Challenges and Future Directions
The review makes it clear: reactivating neonatal regeneration mechanisms in adults is possible—but there are big hurdles:
- Delivery: How do we safely deliver genes, miRNAs, or kinases to the heart? Adenoviruses work in mice but have risks in humans.
- Safety: We need to ensure regeneration doesn’t cause tumors or abnormal growth.
- Specificity: We need to target only cardiomyocytes—not other cells in the heart.
- Mechanistic Gaps: We don’t fully understand how these pathways interact (e.g., how ncRNAs and TFs work together).
But the progress is exciting. Preclinical studies in mice, rats, and human cells have shown that:
- Inhibiting miR-15 or miR-34a improves heart function after MI.
- Activating YAP or ERBB2 triggers adult cardiomyocyte division.
- Low oxygen or ROS scavengers reawaken regenerative potential.
The Road Ahead: From Mice to Humans
The work from Du and colleagues is a critical step toward turning “regeneration” from a lab curiosity to a life-saving therapy. By decoding the molecular language of neonatal heart repair, scientists are edging closer to treatments that could:
- Reduce scarring after heart attacks.
- Replace lost cardiomyocytes without stem cells.
- Reverse heart failure by reactivating the heart’s natural healing ability.
As the review concludes: “The endogenous proliferation of adult cardiomyocytes may be the most promising strategy for heart repair.” For the 26 million people living with heart failure, this research offers a glimmer of hope—proof that the heart’s ability to heal isn’t lost forever, just dormant.
Original Study Citation
Du C, Fan Y, Li YF, Wei TW, Wang LS. Research progress on myocardial regeneration: what is new? Chinese Medical Journal 2020;133:716–723. doi: 10.1097/CM9.0000000000000693
Was this helpful?
0 / 0